These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16417441)

  • 1. Can immunonutrients reduce rejection rates in African Americans?
    Alexander JW; Goodman HR; Alloway RR; Woodle ES
    Exp Clin Transplant; 2005 Dec; 3(2):349-50. PubMed ID: 16417441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunonutrition in kidney and liver transplant recipients.
    Alexander JW
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():34-7. PubMed ID: 24635789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant.
    Alexander JW; Goodman HR; Succop P; Light JA; Kuo PC; Moser AB; James JH; Woodle ES
    Exp Clin Transplant; 2008 Jun; 6(2):118-26. PubMed ID: 18816238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in clinical response to corticosteroid treatment of acute renal allograft rejection.
    Vasquez EM; Benedetti E; Pollak R
    Transplantation; 2001 Jan; 71(2):229-33. PubMed ID: 11213064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower kidney allograft survival in African-Americans compared to Hispanic-Americans with lupus.
    Gonzalez-Suarez ML; Contreras G
    Lupus; 2017 Oct; 26(12):1269-1277. PubMed ID: 28420070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression.
    Gralla J; Le CN; Cooper JE; Wiseman AC
    Clin Transplant; 2014 Mar; 28(3):292-8. PubMed ID: 24476453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunonutrition in reducing complications following organ transplantation.
    Alexander JW
    Transplant Proc; 2000 May; 32(3):574-5. PubMed ID: 10812118
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression.
    Narayanan M; Pankewycz O; El-Ghoroury M; Shihab F; Wiland A; McCague K; Chan L
    Transplantation; 2013 Feb; 95(4):566-72. PubMed ID: 23423268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race.
    Soliman KM; Posadas Salas AC; Taber DJ
    Exp Clin Transplant; 2019 Dec; 17(6):707-713. PubMed ID: 30570456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Daclizumab in a high-risk renal transplant population.
    Meier-Kriesche HU; Kaza H; Palekar SS; Friedman GS; Mulgaonkar SP; Ojo AO; Kaplan B
    Clin Transplant; 2000 Oct; 14(5):509-13. PubMed ID: 11048998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
    Neylan JF
    Transplantation; 1998 Feb; 65(4):515-23. PubMed ID: 9500626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alemtuzumab Induction Is Associated With an Equalization of Outcomes Between White and African American Kidney Transplant Recipients.
    Brooks JT; Mitro G; DeLeonibus A; Qu W; Rees M; Nazzal M; Ortiz J
    Exp Clin Transplant; 2019 Apr; 17(2):196-201. PubMed ID: 29206087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy.
    Zeng X; El-Amm JM; Doshi MD; Singh A; Morawski K; Cincotta E; Losanoff JE; West MS; Gruber SA
    Surgery; 2007 Oct; 142(4):538-44; discussion 544-5. PubMed ID: 17950346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.
    Mehra MR; Uber PA; Scott RL; Park MH
    Transplantation; 2002 Dec; 74(11):1568-73. PubMed ID: 12490790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age.
    Schold JD; Srinivas TR; Braun WE; Shoskes DA; Nurko S; Poggio ED
    Clin Transplant; 2011; 25(5):721-30. PubMed ID: 20964717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients.
    Taber DJ; Belk L; Meadows H; Pilch N; Fleming J; Srinivas T; McGillicuddy J; Bratton C; Chavin K; Baliga P
    Ther Drug Monit; 2013 Dec; 35(6):753-9. PubMed ID: 24061443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients.
    Taber DJ; Gebregziabher MG; Srinivas TR; Chavin KD; Baliga PK; Egede LE
    Pharmacotherapy; 2015 Jun; 35(6):569-77. PubMed ID: 26011276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial.
    Wiland AM; Fink JC; Weir MR; Philosophe B; Blahut S; Weir MR; Copenhaver B; Bartlett ST
    Transplantation; 2004 Feb; 77(3):422-5. PubMed ID: 14966418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney allograft survival of African American and Caucasian American recipients with lupus.
    Contreras G; Li H; Gonzalez-Suarez M; Isakova T; Scialla JJ; Pedraza F; Mattiazzi A; Diaz-Wong R; Sageshima J; Brito Y; Guerra G; Acevedo B; Sajid Ali A; Kershaw TJ; Chen L; Burke GW; Kupin W; Ciancio G; Roth D
    Lupus; 2014 Feb; 23(2):151-8. PubMed ID: 24297643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal.
    Gaber AO; Moore LW; Alloway RR; Woodle ES; Pirsch J; Shihab F; Henning A; Fitzsimmons W; Holman J; Reisfield R; First MR;
    Transplantation; 2013 Feb; 95(4):573-9. PubMed ID: 23423269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.